Navigator Medicines Secures $100M Series A Financing and In-Licenses NAV-240
Key Highlights Navigator Medicines closes $100M Series A financing co-led by RA Capital Management and Forbion. In-licenses NAV-240 and…
Browsing Tag
Wouter Joustra
2 posts
Beacon Therapeutics Secures $170 Million in Series B Funding
Key Highlights $170 million raised in Series B funding led by Forbion. Funds to support AGTC-501 clinical trials for X-Linked Retinitis Pigmentosa (XLRP).…